TITLE

Human α4β2 Nicotinic Acetylcholine Receptor as a Novel Target of Oligomeric α-Synuclein

AUTHOR(S)
Liu, Qiang; Emadi, Sharareh; Shen, Jian-Xin; Sierks, Michael R.; Wu, Jie
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cigarette smoking is associated with a decreased incidence of Parkinson disease (PD) through unknown mechanisms. Interestingly, a decrease in the numbers of α4β2 nicotinic acetylcholine receptors (α4β2-nAChRs) in PD patients suggests an α4β2-nAChR-mediated cholinergic deficit in PD. Although oligomeric forms of α-synuclein have been recognized to be toxic and involved in the pathogenesis of PD, their direct effects on nAChR-mediated cholinergic signaling remains undefined. Here, we report for the first time that oligomeric α-synuclein selectively inhibits human α4β2-nAChR-mediated currents in a dose-dependent, non-competitive and use-independent manner. We show that pre-loading cells with guanyl-5′-yl thiophosphate fails to prevent this inhibition, suggesting that the α-synuclein-induced inhibition of α4β2-nAChR function is not mediated by nAChR internalization. By using a pharmacological approach and cultures expressing transfected human nAChRs, we have shown a clear effect of oligomeric α-synuclein on α4β2-nAChRs, but not on α4β4- or α7-nAChRs, suggesting nAChR subunit selectivity of oligomeric α-synuclein-induced inhibition. In addition, by combining the size exclusion chromatography and atomic force microscopy (AFM) analyses, we find that only large (>4 nm) oligomeric α-synuclein aggregates (but not monomeric, small oligomeric or fibrillar α-synuclein aggregates) exhibit the inhibitory effect on human α4β2-nAChRs. Collectively, we have provided direct evidence that α4β2-nAChR is a sensitive target to mediate oligomeric α-synuclein-induced modulation of cholinergic signaling, and our data imply that therapeutic strategies targeted toward α4β2-nAChRs may have potential for developing new treatments for PD.
ACCESSION #
87624086

 

Related Articles

  • Poly[(3-hexylthiophene)-block-(3-semifluoroalkylthiophene)] for Polymer Solar Cells. Yamada, Ichiko; Takagi, Koji; Hayashi, Yasuhiko; Soga, Tetsuo; Shibata, Norio; Toru, Takeshi // International Journal of Molecular Sciences;Dec2010, Vol. 11 Issue 12, p5027 

    We report the synthesis of poly[(3-hexylthiophene)-block-(3-(4,4,5,5,6,6,7,7,7- nonafluoroheptyl)thiophene)], P(3HT-b-3SFT), carried out by the Grignard Metathesis Method (GRIM). The copolymers composition was determined by ¹H and 19F NMR spectroscopies, and gel permeation chromatography...

  • Examination of the Causes of Instability of Soy Protein Isolate During Storage Through Probing of the Heat-Induced Aggregation. Guo, Feng-Xian; Xiong, Youling; Qin, Fang; Jian, Hua-Jun; Huang, Xiao-Lin; Chen, Jie // Journal of the American Oil Chemists' Society (JAOCS);Aug2015, Vol. 92 Issue 8, p1075 

    This study investigated the mechanism of instability of soy protein isolate (SPI) as influenced by thermal aggregation during SPI preparation. Samples with different degrees of aggregation but similar protein solubility were prepared by heating native SPI (5 % w/v) at 80 or 90 °C for...

  • Isolation, Characterization, and Stability of Discretely- Sized Nanolipoprotein Particles Assembled with Apolipophorin-III. Fischer, Nicholas O.; Blanchette, Craig D.; Segelke, Brent W.; Corzett, Michele; Chromy, Brett A.; Kuhn, Edward A.; Bench, Graham; Hoeprich, Paul D. // PLoS ONE;2010, Vol. 5 Issue 7, p1 

    Background: Nanolipoprotein particles (NLPs) are discoidal, nanometer-sized particles comprised of self-assembled phospholipid membranes and apolipoproteins. NLPs assembled with human apolipoproteins have been used for myriad biotechnology applications, including membrane protein solubilization,...

  • Effects of Chronic Varenicline Treatment on Nicotine, Cocaine, and Concurrent Nicotine+Cocaine Self-Administration. Mello, Nancy K; Fivel, Peter A; Kohut, Stephen J; Carroll, F Ivy // Neuropsychopharmacology;Apr2014, Vol. 39 Issue 5, p1222 

    Nicotine dependence and cocaine abuse are major public health problems, and most cocaine abusers also smoke cigarettes. An ideal treatment medication would reduce both cigarette smoking and cocaine abuse. Varenicline is a clinically available, partial agonist at α4β2* and α6β2*...

  • Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation. Mohamed, Tasnim S.; Jayakar, Selwyn S.; Hamouda, Ayman K.; Bruijnzeel, Adriaan W.; Eid, Ali // Frontiers in Molecular Neuroscience;Nov2015, Vol. 8, p1 

    Nicotine addiction, the result of tobacco use, leads to over six million premature deaths world-wide per year, a number that is expected to increase by a third within the next two decades. While more than half of smokers want and attempt to quit, only a small percentage of smokers are able to...

  • Ribosylation Rapidly Induces α-Synuclein to Form Highly Cytotoxic Molten Globules of Advanced Glycation End Products. Lan Chen; Yan Wei; Xueqing Wang; Rongqiao He // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    Background: Alpha synuclein (α-Syn) is the main component of Lewy bodies which are associated with several neurodegenerative diseases such as Parkinson's disease. While the glycation with D-glucose that results in α-Syn misfold and aggregation has been studied, the effects of glycation...

  • Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease. Ugo Isaias, Ioannis; Spiegel, Jörg; Brumberg, Joachim; Cosgrove, Kelly P.; Marotta, Giorgio; Oishi, Naoya; Higuchi, Takahiro; Küsters, Sebastian; Schiller, Markus; Dillmann, Ulrich; van Dyck, Christopher H.; Buck, Andreas; Herrmann, Ken; Schloegl, Susanne; Volkmann, Jens; Lassmann, Michael; Fassbender, Klaus; Lorenz, Reinhard; Samnick, Samuel // Frontiers in Aging Neuroscience;Aug2014, Vol. 6, p1 

    We investigated in vivo brain nicotinic acetylcholine receptor (nAChR) distribution in cognitively intact subjects with Parkinson's disease (PD) at an early stage of the disease. Fourteen patients and 13 healthy subjects were imaged with single photon emission computed tomography and the...

  • Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease. Isaias, Ioannis U.; Spiegel, Jörg; Brumberg, Joachim; Cosgrove, Kelly P.; Marotta, Giorgio; Oishi, Naoya; Takahiro, Higuchi; Küsters, Sebastian; Schiller, Markus; Dillmann, Ulrich; van Dyck, Chris; Buck, Andreas; Herrmann, Ken; Schloegl, Susanne; Volkmann, Jens; Lassmann, Michael; Fassbender, Klaus; Lorenz, Reinhard; Samnick, Samuel // Frontiers in Aging Neuroscience;Jun2014, Vol. 6, preceding p1 

    We investigated in vivo brain nicotinic acetylcholine receptor (nAChR) distribution in cognitively intact subjects with Parkinson's disease (PD) at an early stage of the disease. Fourteen patients and 13 healthy subjects were imaged with single photon emission computed tomography (SPECT) and the...

  • New Tools for Targeted Disruption of Cholinergic Synaptic Transmission in Drosophila melanogaster Mejia, Monica; Heghinian, Mari D.; Marí, Frank; Godenschwege, Tanja A. // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels. The α7 subtype of nAChRs is involved in neurological pathologies such as Parkinson’s disease, Alzheimer’s disease, addiction, epilepsy and autism spectrum disorders. The Drosophila melanogaster...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics